Screening for Atrial Fibrillation and Hypertension: Time to Act Now
Published: 17 October 2024
-
Views:
126
-
Likes:
7
-
Views:
126
-
Likes:
7
-
Up Next -
10m 30sPart 3 | Session 3 Changing the Game for New AF Screening Initiatives
-
7m 10sPart 3 | Session 4 AF and its Pulse Wave: A New Footprint
-
14m 29sPart 3 | Session 5 Discussion and Q&A
-
9m 26sPart 1 Heart 2 Heart: Breaking Down ESC 2024 Guidelines for Hypertension and AF Management Renate B Schnabel, Alta Schutte, Ben Freedman
-
9m 41sPart 2 Gender Matters: ESC 2024 Insights on Hypertension and AF Management Renate B Schnabel, Alta Schutte
-
6m 29sPart 3 | Session 1 Hypertension and Atrial Fibrillation: Dangerous Bedfellows Ben Freedman
Overview
This video series offers a comprehensive exploration of the latest advancements in the management of hypertension and atrial fibrillation (AF) as presented at ESC 2024 in London. Experts reflect on key updates to the guidelines, examining their impact on clinical practice, with a particular emphasis on gender-specific considerations. The series also delves into the critical relationship between hypertension and AF, highlighting the importance of home-based screening and introducing viewers to the latest innovations in AF detection technology.
For more information visit the Omron Academy following the link here.
Learning Objectives
- To be familiar with the relation between hypertension and AF
- To understand the importance of screening for AF and hypertension at home
- To know the latest insights on AF detection innovations
- To understand the risk of stroke in undiagnosed AF
Target Audience
- Electrophysiologists
- Interventional Cardiologists
- Heart Failure Specialists
- General Practitioners With a Special Interest in Cardiology
More from this programme
Part 1
Heart 2 Heart
Prof Alta Schutte and Prof Renate Schnabel provide an in-depth analysis of the recently presented guidelines for hypertension and AF unveiled at the ESC 2024.
Part 2
Gender Matters
Prof Alta Schutte and Prof Renate Schnabel discuss the hypertension and AF guidelines released at ESC 2024, with a focus on gender-specific considerations.
Part 3
ESC Symposium – Screening for AF and Hypertension: Time to Act Now
In this symposium from ESC 2024 in London, faculty explore the connection between hypertension and AF. They discuss the importance of home-based screening for both conditions and discover the latest innovations in AF detection.
Faculty Biographies
Alta Schutte
Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine
Prof Alta Schutte is Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine at the University of New South Wales, Sydney, Australia; with a joint appointment as Professorial Fellow at the George Institute for Global Health. She has extensive experience in working in the field of hypertension and cardiovascular disease with approx. 450 publications in the field. She serves as Editor of the AHA Journal, Hypertension and is on the Editorial Board of several cardiovascular journals, such as Hypertension, the Journal of Hypertension, Journal of Clinical Hypertension, Journal of Human Hypertension, Current Hypertension Reports and BMC Medicine. She is a Fellow of the European Society of Cardiology, the International Society of Hypertension (ISH) and the Royal Society of South Africa; the Past President of the Southern African Hypertension Society (SAHS); and Past President of the International Society of Hypertension.